Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) is Buildings and Property in United States that focus on New Jersey business. They cover business area such as asset, insulin resistance, related syndrome, obesity, Chatham, New Jersey.
-
New Jersey
-
26 Main Street
Suite 101
Chatham, NJ 07928
United States
Private
assetinsulin resistancerelated syndromeobesityChathamNew Jersey
* We use standard office opening hours in near Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Katana Pharmaceuticals (Assets Related To Insulin Resistance In Chatham, New Jersey) is Buildings and Property business from United States that founded in - ( years old in ), Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) business is focusing on New Jersey.
Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) headquarter office and corporate office address is located in 26 Main Street Suite 101 Chatham, NJ 07928 United States.
Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) was founded in United States.
In , Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) is currently focus on New Jersey sector.
Above is snippet of Google Trends for "New Jersey" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
